{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:52:28Z","timestamp":1773089548017,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3447,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/mt.sj.6300122","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T16:13:06Z","timestamp":1174407186000},"page":"962-970","source":"Crossref","is-referenced-by-count":94,"title":["Engineered Human tmpk\/AZT As a Novel Enzyme\/Prodrug Axis for Suicide Gene Therapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Takeya","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Neschadim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.sj.6300122_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.sj.6300122_bib2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes","volume":"12","author":"Roy","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.sj.6300122_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-45-1-227","article-title":"Anticellular effects of 9-(2-hydroxyethoxymethyl) guanine against herpes simplex virus-transformed cells","volume":"45","author":"Nishiyama","year":"1979","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.sj.6300122_bib4","first-page":"5276","article-title":"Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy","volume":"46","author":"Moolten","year":"1986","journal-title":"Cancer Res"},{"key":"10.1038\/mt.sj.6300122_bib5","first-page":"3989","article-title":"Bystander effect in herpes simplex virus-thymidine kinase\/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication","volume":"60","author":"Mesnil","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/mt.sj.6300122_bib6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1110\/ps.2460102","article-title":"Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity","volume":"11","author":"Kokoris","year":"2002","journal-title":"Protein Sci"},{"key":"10.1038\/mt.sj.6300122_bib7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.gt.3301690","article-title":"T cell transduction and suicide with an enhanced mutant thymidine kinase","volume":"9","author":"Qasim","year":"2002","journal-title":"Gene Ther"},{"key":"10.1038\/mt.sj.6300122_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nm0296-216","article-title":"T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients","volume":"2","author":"Riddell","year":"1996","journal-title":"Nat Med"},{"key":"10.1038\/mt.sj.6300122_bib9","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.sj.6300122_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0163-7258(00)00048-6","article-title":"Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases","volume":"87","author":"Van Rompay","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1038\/mt.sj.6300122_bib11","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3\u2032-azido-3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.sj.6300122_bib12","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/AAC.31.12.1972","article-title":"3\u2032-Azido-3\u2032-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase","volume":"31","author":"St Clair","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/mt.sj.6300122_bib13","doi-asserted-by":"crossref","first-page":"40847","DOI":"10.1074\/jbc.M106743200","article-title":"Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase","volume":"276","author":"Johnson","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.sj.6300122_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm0897-922","article-title":"The bottleneck in AZT activation","volume":"3","author":"Lavie","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/mt.sj.6300122_bib15","doi-asserted-by":"crossref","first-page":"35289","DOI":"10.1074\/jbc.274.50.35289","article-title":"Modifying human thymidylate kinase to potentiate azidothymidine activation","volume":"274","author":"Brundiers","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.sj.6300122_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/jmbi.2000.4175","article-title":"Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP","volume":"304","author":"Ostermann","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.sj.6300122_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1038\/mt.sj.6300122_bib18","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","article-title":"Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors","volume":"101","author":"Yoshimitsu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.sj.6300122_bib19","first-page":"111","article-title":"Selection of retrovirally transduced cells to enhance the efficiency of gene therapy","volume":"109","author":"Medin","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1038\/mt.sj.6300122_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/mthe.2002.0619","article-title":"Sturm und drang over suicidal lymphocytes","volume":"5","author":"Sadelain","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.sj.6300122_bib21","doi-asserted-by":"crossref","first-page":"12075","DOI":"10.1073\/pnas.92.26.12075","article-title":"Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors","volume":"92","author":"Migita","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.sj.6300122_bib22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/blood.V87.5.1754.1754","article-title":"A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients","volume":"87","author":"Medin","year":"1996","journal-title":"Blood"},{"key":"10.1038\/mt.sj.6300122_bib23","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.061020598","article-title":"Preselective gene therapy for Fabry disease","volume":"98","author":"Qin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.sj.6300122_bib24","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1096\/fj.05-4006fje","article-title":"Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms","volume":"19","author":"Siatskas","year":"2005","journal-title":"FASEB J"},{"key":"10.1038\/mt.sj.6300122_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.cgt.7700810","article-title":"Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo","volume":"12","author":"Medin","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.sj.6300122_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.1068893","article-title":"Murine leukemia induced by retroviral gene marking","volume":"296","author":"Li","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.sj.6300122_bib27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0952-7915(96)80128-2","article-title":"Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1","volume":"8","author":"Doody","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/mt.sj.6300122_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1385\/IR:22:2-3:281","article-title":"CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification","volume":"22","author":"Fujimoto","year":"2000","journal-title":"Immunol Res"},{"key":"10.1038\/mt.sj.6300122_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0167-5699(94)90274-7","article-title":"The CD19\/CD21 signal transduction complex of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol Today"},{"key":"10.1038\/mt.sj.6300122_bib30","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.159.7.3278","article-title":"Regulation of B lymphocyte development and activation by the CD19\/CD21\/CD81\/Leu 13 complex requires the cytoplasmic domain of CD19","volume":"159","author":"Sato","year":"1997","journal-title":"J Immunol"},{"key":"10.1038\/mt.sj.6300122_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H","article-title":"Gene directed enzyme\/prodrug therapy of cancer: historical appraisal and future prospectives","volume":"187","author":"Greco","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1038\/mt.sj.6300122_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"Mizuguchi","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/mt.sj.6300122_bib33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0002-8703(89)90886-7","article-title":"Acquired immunodeficiency syndrome and heart disease: the present and the future","volume":"117","author":"Coplan","year":"1989","journal-title":"Am Heart J"},{"key":"10.1038\/mt.sj.6300122_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/taap.2001.9288","article-title":"Zidovudine phosphorylation and mitochondrial toxicity in vitro","volume":"177","author":"Sales","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1038\/mt.sj.6300122_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-510X(99)00126-4","article-title":"Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage","volume":"166","author":"Masini","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1038\/mt.sj.6300122_bib36","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.sj.6300122_bib37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1038\/mt.sj.6300122_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/taap.1996.0172","article-title":"In vivo toxicity of foscarnet and zidovudine given alone or in combination","volume":"139","author":"Omar","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1038\/mt.sj.6300122_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0006-2952(01)00713-4","article-title":"Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes","volume":"62","author":"Cazzalini","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/mt.sj.6300122_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/CT:4:2:155","article-title":"Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity","volume":"4","author":"McKee","year":"2004","journal-title":"Cardiovasc Toxicol"},{"key":"10.1038\/mt.sj.6300122_bib41","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood.V94.10.3551.422k08_3551_3558","article-title":"Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity","volume":"94","author":"Mahmoud","year":"1999","journal-title":"Blood"},{"key":"10.1038\/mt.sj.6300122_bib42","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.sj.6300122_bib43","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1182\/blood.V89.12.4636","article-title":"Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes","volume":"89","author":"Cohen","year":"1997","journal-title":"Blood"},{"key":"10.1038\/mt.sj.6300122_bib44","first-page":"433","article-title":"Developments in suicide genes for preclinical and clinical applications","volume":"2","author":"Spencer","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.sj.6300122_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0167-5699(99)01550-9","article-title":"Suicide genes: past, present and future perspectives","volume":"21","author":"Lal","year":"2000","journal-title":"Immunol Today"},{"key":"10.1038\/mt.sj.6300122_bib46","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nri1729","article-title":"Supernatural T cells: genetic modification of T cells for cancer therapy","volume":"5","author":"Kershaw","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.sj.6300122_bib47","first-page":"412","article-title":"In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice","volume":"25","author":"Chow","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/mt.sj.6300122_bib48","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2002-12-3936","article-title":"CD3\/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects","volume":"102","author":"Jung","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.sj.6300122_bib49","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood.V90.11.4553","volume":"90","author":"Weichold","year":"1997","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616316483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616316483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T03:41:35Z","timestamp":1683776495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616316483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1525001616316483"],"URL":"https:\/\/doi.org\/10.1038\/mt.sj.6300122","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}